Benign calf amyotrophy: clinicopathologic study of 8 patients

Arch Neurol. 2003 Oct;60(10):1415-20. doi: 10.1001/archneur.60.10.1415.

Abstract

Background: The benign focal amyotrophy disorders have been described since 1959 for the upper limbs and since 1981 for the lower limbs. The clinicopathologic features have pointed to a restricted and self-limiting form of motor neuron disease.

Objective: To describe the clinical, electromyographic, and muscle histopathologic features in 8 patients with benign calf amyotrophy.

Design: Retrospective review of patient charts, electromyograms, and muscle histopathology.

Patients and results: Eight patients, aged 37 to 88 years, developed insidiously progressive calf muscle weakness and wasting during 1 to 5 years. The gastrocnemius weakness and wasting were bilateral in 4 patients. Initial progression of symptoms was followed by disease stabilization. None had a history of poliomyelitis or family history of neuromuscular disease. Creatine kinase values were mildly elevated in 5 patients. The electromyographic and muscle histopathologic findings were consistent with a chronic neuropathic disorder. Despite the restricted calf muscle involvement clinically, the electromyographic abnormalities suggested more diffuse lower limb involvement. Further studies, including DNA tests and muscle-based protein studies, excluded several types of inherited neuromuscular disorders.

Conclusions: Benign calf amyotrophy is a variant of the benign focal amyotrophy disorders. The etiology for these disorders is unknown. Studies to exclude other causes of calf amyotrophy and careful follow-up examinations to document disease stabilization are necessary to diagnose this uncommon disorder.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Asian
  • Creatine Kinase / blood
  • Dysferlin
  • Dystrophin / metabolism
  • Electromyography
  • Evoked Potentials, Motor / physiology
  • Humans
  • Immunoenzyme Techniques
  • Leg* / pathology
  • Leg* / physiopathology
  • Magnetic Resonance Imaging
  • Male
  • Membrane Proteins*
  • Middle Aged
  • Muscle Fibers, Skeletal / pathology
  • Muscle Proteins / metabolism
  • Muscle Weakness / pathology
  • Muscle Weakness / physiopathology*
  • Muscle, Skeletal / pathology
  • Muscle, Skeletal / physiopathology
  • Muscular Atrophy / pathology
  • Muscular Atrophy / physiopathology*
  • Neural Conduction / physiology
  • Retrospective Studies
  • Spinal Cord / pathology
  • Spine / pathology

Substances

  • DYSF protein, human
  • Dysferlin
  • Dystrophin
  • Membrane Proteins
  • Muscle Proteins
  • Creatine Kinase